HCA
Harbor Capital Advisors Portfolio holdings
AUM
$2.38B
1-Year Return
20%
This Quarter Return
-2.65%
1 Year Return
+20%
3 Year Return
+97.89%
5 Year Return
–
10 Year Return
–
AUM
$468M
AUM Growth
-$32.3M
(-6.5%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
23.97%
Holding
674
New
13
Increased
155
Reduced
183
Closed
230
Top Buys
| 1 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
$3.45M |
| 2 |
Affirm
AFRM
|
$989K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$689K |
| 4 |
IAUF
iShares Gold Strategy ETF
IAUF
|
$500K |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$408K |
Top Sells
| 1 |
Icon
ICLR
|
$987K |
| 2 |
T-Mobile US
TMUS
|
$874K |
| 3 |
Duolingo
DUOL
|
$666K |
| 4 |
UnitedHealth
UNH
|
$580K |
| 5 |
Masimo
MASI
|
$570K |
Sector Composition
| 1 | Technology | 27.52% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 10.93% |
| 4 | Communication Services | 8.21% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Unity
U
$18.5B
| $67.4K | 0.01% |
2,146
| – | – |
|
427
Definitive Healthcare
DH
$416M
| $66.1K | 0.01% |
8,277
-426
| -5% | -$3.4K |
|
428
Atara Biotherapeutics
ATRA
$90.7M
| $66K | 0.01% |
1,785
-218
| -11% | -$8.07K |
|
|
SHCR
429
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $64.9K | 0.01% |
68,992
+11,112
| +19% | +$10.5K |
|
430
Synlogic
SYBX
$17.1M
| $60.1K | 0.01% |
21,403
+2,029
| +10% | +$5.7K |
|
431
Domo
DOMO
$603M
| $54.2K | 0.01% |
5,524
-1,030
| -16% | -$10.1K |
|
|
FRLN
432
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $53K | 0.01% |
12,504
+1,795
| +17% | +$7.61K |
|
433
Bandwidth Inc
BAND
$473M
| $52.1K | 0.01% |
4,623
+426
| +10% | +$4.8K |
|
|
NXDR
434
Nextdoor Holdings
NXDR
$802M
| $47.8K | 0.01% |
26,290
+7,268
| +38% | +$13.2K |
|
435
Mersana Therapeutics
MRSN
$34M
| $47.1K | 0.01% |
1,482
+628
| +74% | +$19.9K |
|
436
Brown-Forman Class A
BF.A
$13.8B
| $45.3K | 0.01% |
780
| – | – |
|
437
Precision BioSciences
DTIL
$59.8M
| $45.3K | 0.01% |
4,420
+708
| +19% | +$7.25K |
|
438
Tucows
TCX
$198M
| $43.9K | 0.01% |
2,152
+576
| +37% | +$11.8K |
|
439
Semrush
SEMR
$1.15B
| $35.1K | 0.01% |
4,125
-2,345
| -36% | -$19.9K |
|
440
Expensify
EXFY
$178M
| $33.6K | 0.01% |
10,327
+1,268
| +14% | +$4.12K |
|
|
WE
441
DELISTED
WeWork Inc.
WE
| $31.7K | 0.01% |
10,520
+5,604
| +114% | +$16.9K |
|
442
Fate Therapeutics
FATE
$116M
| $31.4K | 0.01% |
14,806
+2,678
| +22% | +$5.68K |
|
443
Nektar Therapeutics
NKTR
$764M
| $29.6K | 0.01% |
3,318
-2,202
| -40% | -$19.7K |
|
444
Vera Bradley
VRA
$60.6M
| $27.3K | 0.01% |
4,130
-401
| -9% | -$2.65K |
|
445
MP Materials
MP
$11.2B
| – | – |
-2,131
| Closed | -$48.8K |
|
446
Maravai LifeSciences
MRVI
$363M
| – | – |
-3,807
| Closed | -$47.3K |
|
447
Matador Resources
MTDR
$6.01B
| – | – |
-379
| Closed | -$19.8K |
|
448
MACOM Technology Solutions
MTSI
$9.67B
| – | – |
-400
| Closed | -$26.2K |
|
449
MaxCyte
MXCT
$150M
| – | – |
-5,652
| Closed | -$25.9K |
|
450
Nordson
NDSN
$12.6B
| – | – |
-88
| Closed | -$21.8K |
|